|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 97.67 USD | +0.11% |
|
+4.95% | -27.75% |
| Dec. 16 | Gordon Haskett Adjusts Price Target on Target to $100 From $95, Maintains Hold Rating | MT |
| Dec. 15 | FDA Issues Warning Letters to Walmart, Target Over ByHeart Infant Formula Recall | MT |
Company Valuation: Target Corporation
Data adjusted to current consolidation scope
| Fiscal Period: February | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 91,927 | 105,038 | 81,512 | 66,673 | 63,192 | 44,226 | - | - |
| Change | - | 14.26% | -22.4% | -18.2% | -5.22% | -30.01% | - | - |
| Enterprise Value (EV) 1 | 96,096 | 112,847 | 95,422 | 78,906 | 74,370 | 56,775 | 57,691 | 58,382 |
| Change | - | 17.43% | -15.44% | -17.31% | -5.75% | -23.66% | 1.61% | 1.2% |
| P/E ratio | 21.2x | 15.5x | 29.6x | 16.2x | 15.6x | 12.4x | 12.9x | 12.4x |
| PBR | 6.42x | 8.05x | 7.26x | 4.96x | 4.28x | 2.84x | 2.67x | 2.71x |
| PEG | - | 0.2x | -0.5x | 0.3x | -17.43x | -1.1x | -3.9x | 3.09x |
| Capitalization / Revenue | 0.98x | 0.99x | 0.75x | 0.62x | 0.59x | 0.42x | 0.41x | 0.4x |
| EV / Revenue | 1.03x | 1.06x | 0.87x | 0.73x | 0.7x | 0.54x | 0.54x | 0.53x |
| EV / EBITDA | 10.7x | 9.43x | 14.5x | 9.18x | 8.59x | 7.1x | 7.12x | 6.95x |
| EV / EBIT | 14.7x | 12.1x | 24.5x | 13.8x | 13.4x | 11.9x | 11.7x | 11.4x |
| EV / FCF | 12.2x | 22.2x | -63.2x | 20.7x | 16.6x | 23.6x | 32.2x | 24.3x |
| FCF Yield | 8.2% | 4.5% | -1.58% | 4.83% | 6.02% | 4.24% | 3.11% | 4.12% |
| Dividend per Share 2 | 2.7 | 3.38 | 4.14 | 4.38 | 4.46 | 4.559 | 4.675 | 4.831 |
| Rate of return | 1.47% | 1.54% | 2.34% | 3.03% | 3.23% | 4.67% | 4.79% | 4.95% |
| EPS 2 | 8.64 | 14.1 | 5.98 | 8.94 | 8.86 | 7.858 | 7.598 | 7.904 |
| Distribution rate | 31.3% | 24% | 69.2% | 49% | 50.3% | 58% | 61.5% | 61.1% |
| Net sales 1 | 93,561 | 106,005 | 109,120 | 107,412 | 106,566 | 104,801 | 106,705 | 109,698 |
| EBITDA 1 | 9,008 | 11,970 | 6,596 | 8,600 | 8,653 | 7,993 | 8,097 | 8,403 |
| EBIT 1 | 6,523 | 9,328 | 3,896 | 5,707 | 5,566 | 4,786 | 4,920 | 5,135 |
| Net income 1 | 4,368 | 6,946 | 2,780 | 4,138 | 4,091 | 3,604 | 3,476 | 3,541 |
| Net Debt 1 | 4,169 | 7,809 | 13,910 | 12,233 | 11,178 | 12,550 | 13,465 | 14,156 |
| Reference price 2 | 183.57 | 219.23 | 177.08 | 144.42 | 137.91 | 97.67 | 97.67 | 97.67 |
| Nbr of stocks (in thousands) | 500,773 | 479,124 | 460,310 | 461,662 | 458,212 | 452,806 | - | - |
| Announcement Date | 3/2/21 | 3/1/22 | 2/28/23 | 3/5/24 | 3/4/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 12.41x | 0.54x | 7.1x | 4.67% | 44.18B | ||
| 42.51x | 1.25x | 26.47x | 0.62% | 382B | ||
| 19.5x | 1.05x | 10.31x | 3.28% | 56.66B | ||
| 42.54x | 8.25x | 25.08x | 0.21% | 39.71B | ||
| 20.48x | 0.78x | 10.61x | 1.76% | 29.26B | ||
| 26.14x | 1.31x | 13.87x | 0.89% | 18.62B | ||
| 29.2x | 2.52x | 18.52x | -.--% | 6.93B | ||
| 15.24x | 0.57x | 7.93x | 4.56% | 5.33B | ||
| -78.2x | 1.02x | 6.42x | 0.61% | 4.75B | ||
| 8.06x | 0.67x | 5.23x | 6.24% | 2.2B | ||
| Average | 13.79x | 1.80x | 13.15x | 2.28% | 58.97B | |
| Weighted average by Cap. | 34.93x | 1.63x | 21.69x | 1.27% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- TGT Stock
- Valuation Target Corporation
Select your edition
All financial news and data tailored to specific country editions
















